Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

Routine mammography for women aged 40-49 years: should mammography screening guidelines be changed in view of current research?

Author: L Nimmo

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

The objective of this study was to establish that current guidelines excluding women aged 40-49 years from the National Breast Screening Programme (NBSP) are justified. Since the conception of the NBSP many articles have been published to fuel the debate on routine mammography for women aged 40-49 years. This study evaluates some of the relevant issues to facilitate making an informed decision on the minimum age for routine screening. …
Metadata
Title
Routine mammography for women aged 40-49 years: should mammography screening guidelines be changed in view of current research?
Author
L Nimmo
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr249

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue

Meeting abstract

Are too many breast cancers missed at assessment?

Meeting abstract

Minimally invasive treatment of the breast

Meeting abstract

Up the creek without a paddle

Meeting abstract

Audit rules OK! The benefits of an internal quality audit programme in the breast screening service

Meeting abstract

Future of breast cancer services

Meeting abstract

Between four walls: what level of privacy do women want?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits